Atara Biotherapeutics (AT20.F) Q4 2024 Earnings

12NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-5.95
-4.56
-3.17
-1.78

Details

Expected EPS
-1.7779306249999998
Actual EPS
-2.7599135
Surprise EPS
-0.98
Surprise Percent
+55.23%

Description

Atara Biotherapeutics (AT20.F) has reported earnings of -2.7599135 per share for Q4 2024.

0 Comments

Share your thoughts